HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41/43 respectors.

Abstract
Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disorder of the colonic mucosa. Risk of colorectal cancer in ulcerative colitis is increased in patients with long-standing disease compared with the general population. Hericium erinaceus (HE) has been used in traditional folk medicine and medicinal cuisine in China, Korea and Japan with anti-gastritis and anti-ulcerative colitis activities. EP-1, a purified unique polysaccharide isolated from HE mycelium, has recently been identified as the active component responsible for anti- ulcerative colitis activity by using a cell model for identification. In this study, our data shows that EP-1 was effective in relieving the symptoms of acetic acid induced UC rats. Based on the Illumina MiSeq platform, 16S rRNA sequencing of the rat colonic contents indicated that the intestinal flora structure remarkably changed in the model rats and the tendency was alleviated to a certain degree by EP-1. The further results showed that in the acetic acid induced UC rats EP-1 modulated the gut microbiota community and increased short chain fatty acids (SCFAs). And immunoblot analyses showed that after treated by EP-1, GPR41 and GPR43 were significantly suppressed expression in colonic tissues of the UC rats. In the meanwhile, EP-1 also showed its antioxidant, anti-inflammatory and enhancing immune activities. Thus, the polysaccharide purified from HE showed potential for anti-UC activity and the complementary and alternative medicine (CAM) herb therapy.
AuthorsShuai Shao, Dandan Wang, Wei Zheng, Xiangyan Li, He Zhang, Daqing Zhao, Mingxing Wang
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 71 Pg. 411-422 (Jun 2019) ISSN: 1878-1705 [Electronic] Netherlands
PMID31059977 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier B.V. All rights reserved.
Chemical References
  • Acetates
  • Antioxidants
  • Fatty Acids, Volatile
  • Ffar2 protein, rat
  • Fungal Polysaccharides
  • Gper1 protein, rat
  • Receptors, G-Protein-Coupled
Topics
  • Acetates
  • Animals
  • Antioxidants (therapeutic use)
  • Basidiomycota (immunology)
  • Colitis, Ulcerative (chemically induced, drug therapy)
  • Disease Models, Animal
  • Fatty Acids, Volatile (metabolism)
  • Female
  • Fungal Polysaccharides (therapeutic use)
  • Gastrointestinal Microbiome (drug effects, physiology)
  • Humans
  • Inflammatory Bowel Diseases (drug therapy)
  • Male
  • Mycelium
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, G-Protein-Coupled (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: